Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1031

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9A
Chunk 1031
---

     * 
  
    Edward
    MacPherson 
     25,000  
     * 
  
    All
    current directors and officers as a group (6 persons) (2) 
     2,788,977  
     14.82%

    5%
    Stockholders 

    Brian
    McNulty(3) 
     5,029,317  
     29.14%

    *
    Represents
    beneficial ownership of less than 1%

81

    (1)
    Unless
    otherwise denoted, the address of each noted person is 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.

    (2)
    Includes
    both founders shares and shares subject to options granted under our 2022 Omnibus Plan that are exercisable as of the Beneficial
    Ownership Date or within 60 days of the Beneficial Ownership Date held as follows: Mr. Aminov, 2,561,200 shares and Ms. Yanez,
    136,111 shares, , Dr. Del Guidice, 25,000 shares, Dr. Shekhat, 41,666 shares, Mr. MacPherson, 25,000 shares, and all current
    officers and directors as a group, 2,256,777 shares. Excludes shares subject to options granted under our 2022 Omnibus Plan that are
    not exercisable within 60 days of the Beneficial Ownership Date.

    (3)
    Includes
    (i) 10,000 shares held directly by Mr. McNulty, (ii) 2,540,270 shares held by the Bay Shore Trust, (iii) 779,047 shares held by the
    Celeste J Williams Lifetime QTIP Trust, (iv) 1,000,000 shares issuable pursuant to warrants held by the Bay Shore Trust that are
    immediately exercisable, and (v) 700,000 shares issuable pursuant to warrants held by MIRALOGX LLC, that are immediately exercisable.
    As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power
    over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of
    the Exchange Act) of the securities